Tag: Channel Therapeutics Corporation

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

In a filing, Channel Therapeutics Corporation revealed its Director Malamut Richard acquired Company’s shares for reported $9825.0 on Sep 12

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Channel Therapeutics Corporation’s filing revealed that its Director Malamut Richard acquired Company’s shares for reported $9825.0 on Sep 12 ’24.